Skip to main content

Advertisement

Log in

Increased faecal calprotectin predicts recurrence of colonic diverticulitis

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background and aims

Colonic diverticulitis shows a high recurrence rate, but the role of faecal markers in predicting recurrence is unknown. The aim of this study was to investigate the role of faecal calprotectin (FC) in predicting recurrence of diverticulitis.

Patients/methods

A prospective cohort study was performed on 54 patients suffering from acute uncomplicated diverticulitis (AUD) diagnosed by computerized tomography (CT). After remission, patients underwent to clinical follow-up every 2 months. After remission and during the follow-up, FC was analysed. Recurrence of diverticulitis was defined as return to our observation due to left lower-quadrant pain with or without other symptoms (e.g. fever), associated with leucocytosis and/or increased C-reactive protein (CRP). Presence of diverticulitis was confirmed by means of CT.

Results/findings

The mean follow-up was 20 months (range 12–24 months). Forty-eight patients were available for the final evaluation, and six patients were lost to follow-up. During follow-up, increased FC was detected in 17 (35.4 %) patients and diverticulitis recurred in eight patients (16.7 %). Diverticulitis recurred in eight (16.7 %) patients: seven (87.5 %) patients showed increased FC during the follow-up, and only one (12.5 %) patient with recurrent diverticulitis did not show increased FC. Diverticulitis recurrence was strictly related to the presence of abnormal FC test during follow-up.

Conclusions

In the present prospective study, increased FC was found to be predictive of diverticulitis recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sheth AA, Longo W, Floch MH (2008) Diverticular disease and diverticulitis. Am J Gastroenterol 103:1550–1556

    Article  PubMed  Google Scholar 

  2. Tursi A (2007) New physiopathological and therapeutic approaches to diverticular disease of the colon. Expert Opin Pharmacother 8:299–307

    Article  CAS  PubMed  Google Scholar 

  3. Tursi A, Brandimarte G, Giorgetti G, Elisei W, Maiorano M, Aiello F (2008) The clinical picture of uncomplicated versus complicated diverticulitis of the colon. Dig Dis Sci 53:2474–2479

    Article  PubMed  Google Scholar 

  4. Etzioni DA, Chiu VY, Cannom RR, Burchette RJ, Haigh PI, Abbas MA (2010) Outpatient treatment of acute diverticulitis: rates and predictors of failure. Dis Colon Rectum 53:861–865

    Article  PubMed  Google Scholar 

  5. Evans J, Kozol R, Frederick W, Voytavich A, Pennoyer W, Lukianoff A, Lardner J (2008) Does a 48-hour rule predict outcomes in patients with acute sigmoid diverticulitis? J Gastrointest Surg 12:577–582

    Article  PubMed  Google Scholar 

  6. Strate LL, Liu YL, Aldoori WH, Syngal S, Giovannucci EL (2009) Obesity increases the risks of diverticulitis and diverticular bleeding. Gastroenterology 136:115–122

    Article  PubMed Central  PubMed  Google Scholar 

  7. Tursi A, Elisei W, Giorgetti GM, Inchingolo CD, Nenna R, Picchio M, Brandimarte G (2013) Detection of endoscopic and histological inflammation after an attack of colonic diverticulitis is associated with higher diverticulitis recurrence. J Gastrointest Liver Dis 22:13–19

    Google Scholar 

  8. Bischoff SC, Grabowsky J, Manns MP (1997) Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci 42:394–403

    Article  CAS  PubMed  Google Scholar 

  9. Poullis A, Foster R, Mendall MA, Fagerhol MK (2003) Emerging role of calprotectin in gastroenterology. J Gastroenterol Hepatol 18:756–762

    Article  CAS  PubMed  Google Scholar 

  10. Voganatsi A, Panyutich A, Miyasaki KT, Murthy RK (2001) Mechanism of extracellular release of human neutrophil calprotectin complex. J Leukoc Biol 70:130–134

    CAS  PubMed  Google Scholar 

  11. Roseth AG, Fagerhol MK, Aadland E, Schjonsby H (1992) Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 27:793–798

    Article  CAS  PubMed  Google Scholar 

  12. Johne B, Fagerhol MK, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF et al (1997) Functional and clinical aspects of the myelomonocytic protein calprotectin. J Clin Pathol Mol Pathol 50:113–123

    Article  CAS  Google Scholar 

  13. Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I (2000) Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 119:15–22

    Article  CAS  PubMed  Google Scholar 

  14. Costa F, Mumolo MG, Ceccarelli L et al (2005) Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s disease. Gut 54:364–368

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. D’Inca R, Dal Pont E, Di Leo V et al (2008) Can calprotectin predict relapse risk in inflammatory bowel disease? Am J Gastroenterol 103:2007–2014

    Article  PubMed  Google Scholar 

  16. Walkiewicz D, Werlin SL, Fish D, Scanlon M, Hanaway P, Kugathasan S (2008) Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease. Inflamm Bowel Dis 14:669–673

    Article  PubMed  Google Scholar 

  17. Gisbert JP, Bermejo F, Perez-Calle JL et al (2009) Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis 15:1190–1198

    Article  PubMed  Google Scholar 

  18. Garcia-Sanchez V, Iglesias-Flores E, Gonzalez R et al (2010) Does fecal calprotectin predict relapse in patients with Crohn’s disease and ulcerative colitis? J Crohns Colitis 4:144–152

    Article  PubMed  Google Scholar 

  19. Tursi A, Brandimarte G, Elisei W, Giorgetti GM, Inchingolo CD, Aiello F (2009) Faecal calprotectin in colonic diverticular disease: a case–control study. Int J Colorectal Dis 24:49–55

    Article  PubMed  Google Scholar 

  20. Kaiser AM, Jiang JK, Lake JP et al (2005) The management of complicated diverticulitis and the role of computed tomography. Am J Gastroenterol 100:910–917

    Article  PubMed  Google Scholar 

  21. Vestergaard TA, Nielsen SL, Dahlerup JF, Hornung N (2008) Fecal calprotectin: assessment of a rapid test. Scand J Clin Lab Invest 68:343–347

    Article  CAS  PubMed  Google Scholar 

  22. Sandler RS, Everhart JE, Donowitz M et al (2002) The burden of selected digestive diseases in the United States. Gastroenterology 122:1500–1511

    Article  PubMed  Google Scholar 

  23. Ambrosetti P, Becker C, Terrier F (2002) Colonic diverticulitis: impact of imaging on surgical management—a prospective study of 542 patients. Eur Radiol 12:1145–1149

    Article  CAS  PubMed  Google Scholar 

  24. Allez M, Lémann M (2010) Role of endoscopy in predicting the disease course in inflammatory bowel disease. World J Gastroenterol 16:2626–2632

    Article  PubMed Central  PubMed  Google Scholar 

  25. Parente F, Molteni M, Marino B et al (2010) Are colonoscopy and bowel ultrasound useful for assessing response to short-term therapy and predicting disease outcome of moderate-to-severe forms of ulcerative colitis?: A prospective study. Am J Gastroenterol 105:1150–1157

    Article  PubMed  Google Scholar 

  26. Rutgeerts P, Vermeire S, Van Assche G (2008) What is the role of endoscopy in predicting Crohn’s disease relapse or course? Inflamm Bowel Dis 14(Suppl 2):S183–S184

    Article  PubMed  Google Scholar 

  27. Bitton A, Peppercorn MA, Antonioli DA et al (2001) Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 120:13–20

    Article  CAS  PubMed  Google Scholar 

  28. Ruffolo C, Scarpa M, Faggian D et al (2010) Subclinical intestinal inflammation in patients with Crohn’s disease following bowel resection: a smoldering fire. J Gastrointest Surg 14:24–31

    Article  PubMed  Google Scholar 

  29. Tursi A, Elisei W, Brandimarte G, Giorgetti GM, Aiello F (2010) Predictive value of serologic markers of degree of histologic damage in acute uncomplicated colonic diverticulitis. J Clin Gastroenterol 44:702–706

    Article  PubMed  Google Scholar 

  30. Burri E, Beglinger C (2012) Faecal calprotectin—a useful too in the management of inflammatory bowel disease. Swiss Med Wkly 142:w13557

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Tursi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tursi, A., Elisei, W., Picchio, M. et al. Increased faecal calprotectin predicts recurrence of colonic diverticulitis. Int J Colorectal Dis 29, 931–935 (2014). https://doi.org/10.1007/s00384-014-1884-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-014-1884-0

Keywords

Navigation